4-((2-(2-Oxo-2-(o-tolylamino)acetyl)hydrazono)methyl)phenyl 3-bromobenzoate

Catalog No. :
ACVSHB597
CAS No. :
881660-22-6
Molecular Formula :
C23H18BrN3O4
Molecular Weight :
480.32

IUPAC Name:(E)-4-((2-(2-oxo-2-(o-tolylamino)acetyl)hydrazineylidene)methyl)phenyl 3-bromobenzoate

4-((2-(2-Oxo-2-(o-tolylamino)acetyl)hydrazono)methyl)phenyl 3-bromobenzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((2-(2-Oxo-2-(o-tolylamino)acetyl)hydrazono)methyl)phenyl 3-bromobenzoate
IUPAC Name(E)-4-((2-(2-oxo-2-(o-tolylamino)acetyl)hydrazineylidene)methyl)phenyl 3-bromobenzoate
MDL No.MFCD08282069
Molecular FormulaC23H18BrN3O4
Molecular Weight480.32
SMILESO=C(OC1=CC=C(/C=N/NC(C(NC2=CC=CC=C2C)=O)=O)C=C1)C3=CC=CC(Br)=C3
InChI KeyISCGIDRNRKMUCL-AFUMVMLFSA-N
Synonym4-[(1Z)-({[(2-methylphenyl)carbamoyl]formamido}imino)methyl]phenyl 3-bromobenzoate;4-(2-(OXO(2-TOLUIDINO)ACETYL)CARBOHYDRAZONOYL)PHENYL 3-BROMOBENZOATE
CAS No.881660-22-6

Safety Data

Pictogram
Harmful or irritantHealth hazardEnvironmental hazard
Signal Word
Gefahr
Hazard Statement(s)
H302-H319-H372-H410
Precautionary Statement(s)
P260-P264-P273-P301+P312-P305+P351+P338-P314

Synthetic Route by SureRoute

1. ACVSHB597 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEADR356 route compound structure diagram
    ACEADR356585-76-2 In Stock
  4. Then
  5. ACVSHB597 route product structure diagram
    ACVSHB597881660-22-6
Inquiry

2. ACVSHB597 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVSHB597 route product structure diagram
    ACVSHB597881660-22-6
Inquiry

Comments (0)